Щоденний перегляд необхідності центрального катетера — the daily clinical-reasoning loop that asks "does this patient still need this line?" instead of leaving it in by default
Central line-associated bloodstream infection (CLABSI) risk is not a fixed, one-time probability assigned at insertion — it is a cumulative hazard that compounds with every additional catheter-day. This single fact is the entire justification for daily necessity review as a distinct prevention practice, separate from and complementary to insertion technique and maintenance bundle compliance. A perfectly inserted, perfectly maintained line that stays in three days longer than needed still adds three days of avoidable risk.
A central venous catheter is a permanent breach of the skin barrier and a foreign surface sitting directly in the bloodstream. From the moment of insertion, two risk-generating processes run continuously:
• Extraluminal colonization: skin flora migrate along the external catheter surface from the insertion site toward the bloodstream, a process that becomes more likely the longer the dwell time and the more often the dressing or site is disturbed. • Intraluminal colonization: organisms introduced at hub connections during medication administration, blood draws, or line access form biofilm on the internal lumen surface — biofilm that thickens and becomes harder to clear the longer the line remains cannulated.
Both pathways are time-dependent, not insertion-dependent. A line placed with flawless maximal-sterile-barrier technique on day 0 does not confer lasting immunity — it simply starts the clock at a lower initial risk. By day 10–14, cumulative exposure to both pathways has typically overtaken any advantage from a clean insertion. This is why insertion bundles and necessity review are not substitutes for each other: insertion technique sets the starting risk, but only timely removal caps the cumulative risk.
The clinical implication is blunt: the single highest-yield intervention available on any given hospital day, for any given catheter, is often not "improve technique" but simply "ask whether the line is still needed" — because every day of unnecessary dwell time is a day of pure, avoidable risk with zero offsetting clinical benefit.
CLABSI-prevention frameworks (CDC, SHEA/IDSA, WHO) typically describe three layered defenses, each targeting a different phase of the catheter lifecycle:
1. Insertion bundle — maximal sterile barrier precautions, chlorhexidine skin antisepsis, optimal site selection, hand hygiene, ultrasound guidance. Targets the moment of placement. 2. Maintenance bundle — daily site inspection, dressing integrity, hub disinfection ("scrub the hub"), aseptic access technique. Targets the ongoing dwell period, keeping the daily risk rate as low as possible while the line is in. 3. Necessity review — the daily question of whether the line should still exist at all. Targets the duration variable directly, which is the only lever that can drive cumulative risk toward zero rather than merely suppressing the daily rate.
These three layers are complementary, not redundant. A unit can have excellent insertion and maintenance compliance and still carry a high aggregate CLABSI burden if lines are systematically left in longer than clinically justified — because duration multiplies whatever the residual daily risk is, however low. Necessity review is therefore the layer that converts good bundle compliance into a genuinely low cumulative infection burden.
Surveillance data consistently show CLABSI incidence expressed as events per 1,000 catheter-days — a rate metric that implicitly encodes the cumulative-risk principle: the denominator is catheter-days, not catheters. Two units can insert identical numbers of lines with identical technique, yet the unit that keeps catheters in place longer on average will accrue more total catheter-days and, at the same daily rate, more absolute infections.
This reframes the clinical question away from "is this line dangerous?" (most single days are individually low-risk) toward "how many more risk-days am I about to add by not removing this line today?" A line with no remaining indication that stays in for five more "just in case" days adds five catheter-days of pure downside with no corresponding clinical upside — the same five days would have zero risk if the line were simply removed. Daily necessity review operationalizes this reframing into a repeatable bedside habit rather than an abstract statistic.
Left to informal judgment, central line removal decisions default toward inertia — a line stays in because no one actively decided to take it out. Structured necessity review inverts this default: each line is checked every day against a short, explicit list of ongoing indications, and the line is presumed removable unless at least one indication is actively and currently met.
While local protocols vary in exact wording, most structured daily-review tools converge on a small set of ongoing indications that justify continued central access. A line is considered still necessary if any one of the following remains actively true today — not "was true three days ago," not "might become true tomorrow":
• Vasopressor or vasoactive infusion requirement — medications such as norepinephrine, vasopressin, or high-dose dopamine that require reliable central delivery for safety and titration. • Frequent blood sampling need — a genuine ongoing requirement for multiple daily draws that cannot reasonably be met with peripheral venipuncture, not a convenience preference. • No usable peripheral venous access — documented, current difficulty establishing or maintaining peripheral IV access, not a historical difficulty that has since resolved. • Total parenteral nutrition (TPN) or specific IV medications requiring central access — hyperosmolar solutions, vesicants, or drugs whose product labeling specifically requires central administration (e.g., certain vasopressors, concentrated potassium, some chemotherapeutic agents).
Any other ongoing central-access need specific to the clinical scenario should be explicitly named, but the review deliberately keeps the checklist short: a long list of vague possible justifications defeats the purpose by making "yes" the easy default answer again.
Unstructured necessity assessment — simply asking a busy clinician "does this patient still need the line?" during rounds — reliably underperforms a structured checklist for several well-documented reasons:
• Anchoring on the original indication: clinicians tend to recall why the line was placed, not re-derive whether that reason still applies today. A line placed for an indication that resolved three days ago is easy to mentally file as "still needed" simply because that was the original story. • Cognitive load competition: on a service with a dozen other active problems, the line is rarely the most urgent item, so it is quietly deferred rather than actively evaluated. • Absence of a forcing function: without an explicit checklist item, there is no natural trigger that surfaces the question at all — it has to be actively remembered.
A structured criteria list converts an easily-skipped judgment call into a fast, concrete verification task: read four short lines, check whether each is currently true, done. This lowers the effort required to reach the correct answer and removes the anchoring bias toward the original indication.
The critical design feature is the default direction: the checklist is framed so that the absence of any met criterion is itself the actionable finding ("no criteria met → line should be removed"), rather than requiring someone to affirmatively argue for removal against institutional inertia favoring retention.
The most common failure mode in necessity review is not omitting a criterion from the checklist — it is marking a criterion as "met" based on outdated information rather than the current clinical state. Robust review practice requires re-verifying each criterion against present-tense evidence:
• Vasopressors: is an infusion currently running, or was it weaned off yesterday and simply not yet reflected in the mental problem list? • Blood draws: is the ordered frequency for today genuinely unachievable peripherally, or has the draw frequency already stepped down as the patient stabilized? • Peripheral access: has a peripheral IV attempt actually been tried recently, or is "difficult access" being carried forward from an admission note written a week ago? • TPN/IV medications: has the medication list been reconciled today, or is a central-requiring drug still listed from an order that was already discontinued?
This is precisely why the review must be daily rather than periodic — clinical status changes quickly enough that a criterion true on Monday can be false by Wednesday, and only a same-day recheck reliably catches the transition.
| Product | Indication | Trial Design | Key Result |
|---|---|---|---|
| Vasopressor / vasoactive infusion | Norepinephrine, vasopressin, high-dose dopamine, etc. | Reliable, rapid central delivery required for titration safety | Clear, objectively verifiable — infusion running or not |
| Frequent blood sampling | Multiple daily draws exceeding reasonable peripheral capacity | Genuine ongoing lab-intensity need, not convenience | Should decline as acuity resolves — re-verify daily |
| No usable peripheral access | Documented current difficulty, not historical | Central line substitutes for unobtainable peripheral IV | Re-attempt peripheral access before defaulting to "met" |
| TPN / specific central-requiring IV meds | Hyperosmolar nutrition, vesicants, labeled central-only drugs | Peripheral administration would be unsafe or contraindicated | Reconcile med list daily — discontinued orders drop this criterion |
A necessity checklist that exists on paper but is never actually asked out loud accomplishes nothing. The decisive design step is embedding the necessity question as a standing, unavoidable prompt inside the existing daily rounds structure — so that raising it requires no extra meeting, no extra memory, and no individual clinician's initiative to remember it on a busy day.
Quality-improvement literature on line-day reduction converges on a consistent finding: education campaigns and reminder posters produce short-lived improvement that decays within weeks, while structural changes to the rounds workflow produce durable improvement that persists because it no longer depends on individual vigilance.
The mechanism is straightforward. Any given clinician, on any given day, is managing many competing priorities. A line that is functioning normally, causing no visible problem, and was clinically justified at some point in the past generates no natural signal demanding attention — it is invisible by default. Only an external structural prompt reliably surfaces it. Embedding the necessity question directly into the rounds checklist (alongside items like medication reconciliation, mobility status, and discharge planning) ensures the question is asked whether or not any individual happens to remember it that day.
Structured necessity review works best as a genuinely multidisciplinary checkpoint rather than a single physician's unilateral call, for practical reasons specific to how information is distributed across a care team:
• Nursing: has the most continuous bedside visibility into whether the line is actually being accessed, how often, and whether peripheral access has been attempted or would realistically be tolerated. • Physician/APP: holds the clinical reasoning behind the original indication and is positioned to judge whether that indication still applies given the day's labs, hemodynamics, and treatment plan. • Pharmacy: has the clearest real-time view of the active medication list and can flag when a central-requiring drug has been discontinued or when an IV medication could be safely converted to a route not requiring central access.
Asking each role the same structured question independently — rather than relying on one person to synthesize all three perspectives from memory — catches cases where, for example, the physician still mentally associates the line with an indication that pharmacy already knows was discontinued that morning.
Units that formally assign the necessity question to a specific point in the rounds script — rather than leaving it as an optional aside — consistently report shorter median catheter dwell times, because the question converts from something that might come up to something that always comes up.
Effective integration tends to share a few concrete features regardless of the specific electronic or paper tool used:
• A visible line-day counter attached to the patient's rounding summary, so the accumulating duration is never invisible. • The four structured criteria (Stage 2) pre-populated or quickly checkable at the bedside, rather than requiring the team to reconstruct the indication from memory each day. • An explicit verbal or documented answer required for every line, every day — "still needed, criteria X and Y met" or "no criteria met, plan for removal" — rather than silence being interpreted as "leave it in." • A clear escalation path when the team is uncertain (e.g., anticipated future need) rather than resolving ambiguity by default continuation, which is addressed further in Stage 4.
The goal is to make skipping the question harder than answering it — flipping the default so that active reconsideration, not passive retention, is the path of least resistance.
Structured daily review exists precisely because a specific, recurring set of human and organizational barriers otherwise keeps central lines in place well past the point of genuine clinical need. Understanding these barriers explicitly is what allows a review process to be designed to defeat them, rather than simply hoping good intentions will suffice.
Diagnostic inertia describes the tendency for an established clinical decision to persist unchallenged simply because it was made correctly at some point in the past, not because it remains correct today. Applied to central lines, this manifests as the catheter fading into the background of the clinical picture — present on every exam, listed on every problem summary, but never actively re-evaluated as a decision that could be reversed.
The line becomes part of the patient's "baseline state" in the team's mental model rather than an active intervention still requiring ongoing justification. This is precisely the failure mode that a structured, dated necessity checklist is designed to interrupt: it forces a fresh, present-tense answer each day rather than allowing the previous day's implicit answer to simply carry forward unchallenged.
A second common barrier is the impulse to retain a line because it might be needed again soon — the patient could deteriorate, could need another round of vasopressors, could need TPN restarted next week. This reasoning feels clinically cautious, but it inverts the actual risk-benefit calculation: it accepts a certain, accumulating infection risk today in exchange for avoiding a hypothetical, not-yet-necessary re-insertion at an unknown future date.
In most cases, if the anticipated need materializes, a new line can be placed at that time with a fresh, low starting risk — which is a better trade than carrying present-day cumulative risk for an indication that does not yet exist. Necessity review protocols generally treat "might need it later" as explicitly insufficient justification for continued retention today; only currently active criteria (Stage 2) count. Genuinely high-probability, near-term anticipated need (e.g., a scheduled procedure the next morning) is a legitimate exception, but it should be named and documented as such, not used as a default catch-all.
Empirically, the single most frequent reason a line stays in past its clinical need is not a deliberate judgment that it is still required — it is that no one actively asked the question that day. On a busy unit managing many patients and many higher-acuity problems, a functioning, complication-free central line generates no alarm, no abnormal value, and no natural prompt for review. It is simply not thought about.
This is the barrier most directly targeted by Stage 3's rounds integration: converting the necessity question from something that requires someone to remember it into something the rounds structure asks automatically, every day, for every line. Where diagnostic inertia and anticipated need are reasoning errors that a structured checklist can correct by forcing an explicit answer, simple non-reconsideration is an attention failure that only a mandatory, unavoidable prompt reliably fixes.
All three barriers share a common structural weakness: none of them survive a mandatory, dated, explicitly-answered daily prompt. Diagnostic inertia is broken by forcing a fresh present-tense answer; "just in case" reasoning is disallowed as a criterion; and simple forgetting is prevented by making the question a standing, unskippable rounds item.
A necessity review that happens verbally during rounds but leaves no trace accomplishes only half its purpose. The final step of the daily cycle is explicit documentation of the assessment itself — which criteria were checked, what was found, and what decision followed — converting a private clinical judgment into an auditable record with clear accountability.
Effective necessity-review documentation is deliberately brief — a structured note, not a narrative essay — but it must capture enough to be independently interpretable later:
• Which of the structured criteria (Stage 2) were assessed and which, if any, were currently met, with enough specificity to distinguish "actively verified today" from "assumed unchanged from yesterday." • The resulting decision: continue the line, or proceed with removal. • A brief rationale, especially when the decision is to continue despite few or no criteria being clearly met (e.g., a named, time-limited anticipated need rather than an open-ended "just in case"). • The identity of the clinician or team making the assessment, so the decision is attributable rather than anonymous.
This is intentionally lighter-weight than a full progress note — the goal is a fast, structured entry that a chart reviewer or quality-improvement audit can later scan across many patient-days without needing to parse free text.
The act of requiring an explicit, attributable documented answer changes the underlying decision dynamics even independent of any later review. An undocumented default ("the line is still in, nobody said otherwise") is psychologically and organizationally easy to sustain indefinitely — there is no moment at which anyone has to actively commit to the position that continued retention is justified.
A documentation requirement forces that commitment into the open daily: someone has to write, in effect, "I reviewed this today and concluded the line should stay in, because X." That sentence is harder to write truthfully when X is genuinely weak (no criteria met, vague anticipated need) than it is to simply say nothing and let the line remain by default. Documentation therefore functions as much as a decision-quality lever in the moment as it does a record for later review.
The single clearest sign that a unit's necessity-review process is working is not the existence of a checklist — it is a chart audit finding very few catheter-days where the documented rationale for continuation is weak or absent, because weak justifications become visible and uncomfortable the moment they must be written down.
Beyond individual accountability, aggregated necessity-review documentation becomes the raw material for unit-level and hospital-level quality improvement:
• Retrospective chart audits can quantify the proportion of catheter-days where no necessity criterion was documented as met — a direct, defensible estimate of avoidable dwell time, distinct from overall CLABSI rate, which is diluted by many well-justified catheter-days. • Trends over time reveal whether rounds integration (Stage 3) is actually functioning as designed, or whether the checklist has quietly become a rubber-stamp exercise with criteria marked "met" without genuine daily re-verification. • Outlier patterns — specific services, specific clinicians, specific line types with disproportionately long unjustified dwell times — can be identified and addressed with targeted feedback rather than blanket policy changes.
This closes the loop from Stage 1's foundational principle: cumulative risk is driven by duration, duration is driven by daily decisions, daily decisions are only as good as the process forcing them to happen, and that process is only durably effective if its outputs are documented well enough to be checked, corrected, and improved over time.